Express Scripts Holding Company (ESRX): Playing the Pharmaceutical Distribution Stocks

Page 1 of 2

According to Barron’s, Maxim Group ranked Express Scripts Holding Company (NASDAQ:ESRX) as a buy after its better-than-estimated first quarter earnings results. Since the beginning of the year, Express Scripts has experienced a gain of 10.4%, lower than the S&P 500’s gain of nearly 11%. However, in a longer historical time horizon of 5 years, the company has gained more than 67.5%, leaving the S&P 500 in the dust with only a 12.3% gain. Express Scripts Holding Company (NASDAQ:ESRX) is currently in the portfolio of many famous investment managers, including David Rolfe, Wallace Weitz, Glenn Greenberg and Ken Fisher. Should we get into Express Scripts Holding Company (NASDAQ:ESRX) at its current trading price? Let’s find out.

Huge jump in revenue due to Medco’s acquisition

Express Scripts is considered the biggest player in pharmacy benefit management (PBM), providing various services to wide range of clients including health insurers, managed care organizations, workers’ compensation plans and government health programs. Most of its revenue derived from PBM. In the PBM segment, most if its revenue, $57.76 billion, or 63% of the total 2012 revenue, was generated from network revenue, while home delivery and specialty revenue contributed more than $33 billion in revenue.

In the first quarter of 2013, Express Scripts Holding Company (NASDAQ:ESRX) experienced a huge growth in both its top line and bottom line. Revenue came in at more than $26 billion, more than double the revenue in the first quarter 2012 of only $12.1 billion. The significant increase in its revenue was due to the inclusion of Medco’s operating results. The company’s chairman and CEO commented that a year after Medco’s acquisition the combined company was better than the sum of its parts.

Net income rose as much as 39.2%, from $267.8 million to $373 million. However, EPS experienced a drop by more than 18% to $0.45. The higher net income but lower EPS was due to the significant increase in the total number of outstanding shares, from nearly 490 million shares in the first quarter last year to 832.5 million shares. Express Scripts Holding Company (NASDAQ:ESRX) employed a reasonable amount of debt in its operations. As of March 2013, it had $23.63 billion in total stockholders’ equity, nearly $2 billion in cash, and more than $14.4 billion in both long and short-term debt.

Walgreen Company (NYSE:WAG) and AmerisourceBergen Corp. (NYSE:ABC) might be better picks?

Two years ago, Express Scripts Holding Company (NASDAQ:ESRX) had a dispute on the prescription issue with Walgreen Company (NYSE:WAG). When the company’s exclusive contract with Walgreen was no longer valid, Express Scripts could expand its partnership with other companies, selling its services via various channels. For Walgreen, after the dispute, the stock price experienced a serious free fall. Walgreen lost around $4 billion in revenue because of the dispute. However, Walgreen’s share price has regained its momentum, rising significantly from $32 per share to nearly $49 per share within just more than a year.

Recently, Walgreen and its partner, Alliance Boots, made a big move by signing a 10-year agreement with distributor AmerisourceBergen Corp. (NYSE:ABC) for the distribution of pharmaceuticals to Walgreen’s retail stores. This agreement was reported to be worth as much as $400 billion over 10 years. The partnership between the two will have the huge impact on the pharmaceutical industry because of their market leading positions. Walgreen Company (NYSE:WAG) is the largest U.S. pharmaceutical operator, with nearly 8,400 stores including drugstores, specialty pharmacies, worksite health and wellness centers, and infusion and respiratory services facilities. AmerisourceBergen Corp. (NYSE:ABC) is one of the largest global pharmaceutical services companies, with more than 98% of its revenue coming from pharmaceutical distribution. Interestingly, the largest customer of AmerisourceBergen used to be Medco, representing around 17% of its total revenue in fiscal 2012. Jeff Jonas, a portfolio manager at Gamco Investors commented on the deal:

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

All In: The 7 Richest Poker Players in the World

Abracadabra: The 10 Best Magicians in the World

The 10 Richest Asian Countries in the World in 2014

Eyes in the Sky: 10 Things You Need to Know About Drones

Rising Stars: The 6 Best Silicon Valley Startups

Military Muscle: The 5 Most Advanced Armies in South America

All that Glitters: The 7 Most Luxurious Jewelry Brands in the World

5 Things You Didn’t Know About ISIS but Should

Empowering Your Money: The 5 Best Energy Stocks to Invest In

The 11 Best Android Apps You Can’t Get on iOS

The 10 Most Important International Conflicts in 2014

Mood Enhancers: The 20 Most Uplifting Songs of all Time

Lover Beware: The 8 Countries that Cheat the Most

Breath of Fresh Air: The 25 Countries with the Best Air Quality on the Planet

Singles Beware: The 8 Worst Mistakes Made on First Dates

Healthy and Happy: The 10 Countries with Lowest Healthcare Costs

The 6 Best Company Team Building Activities to Build Workplace Camaraderie

Ships Ahoy: The 10 Busiest Shipping Ports in the World

10 Productivity Tips to Save You Time and Help You Do More With Less

Grab a Bite: The Most Popular Fast Food Restaurants in America

Friday Night Thirst: The 10 Most Popular Cocktails in the World

The 6 Greatest Unsolved Mysteries We May Never Figure Out

7 Useless Products You Never Should’ve Bought

The 5 Reasons Why You’re Single and Miserable

The 7 Most Addictive Foods in the World We Can’t Stop Eating (Even Though We Should)

5 Amazing Places You Can Swim with Dolphins

The Top 7 Most Livable Countries In The World

The 10 Most Expensive Baseball Cards Ever Pulled From A Pack

The 5 Easiest Second Languages to Learn for English Speakers

Silver Spoon: The 6 Richest Families in the World

The 20 Countries with the Largest Prison Populations in the World

The Top 10 Richest Actors in the World

The 10 Best Airline Stocks to Invest In Before They Fly Too High

Burger Kings: The 10 Most Expensive Burgers in the World

The 10 Most Ethnically Diverse Countries in the World

The 10 Most Exclusive Credit Cards in the World

The 10 Most Expensive Cruise Ships in the World

The 10 Fastest Supercomputers in the World

The 10 Best Countries for Doing Business 2015

6 Most Expensive Fruits In The World

10 Worst Airlines in the World

The 10 Biggest Tax Havens in the World to Stash Your Money

The 15 Most Murderous Countries in the World

10 Largest Colleges in the World: Bigger Isn’t Always Better

Comedians in Cars Getting Coffee: The 6 Comedians Seinfeld Needs to Interview

Easy Money: The 10 Most Successful Investors in the World Today

The 10 Most Deadly Diseases in the World Today

The 5 Most Expensive Luxury Motorhomes in the World

20 Largest Stock Exchanges in the World

6 Richest Painters In The World 2014

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!